LCINQ — Lannett Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.32m
- $582.17m
- $340.58m
Annual cashflow statement for Lannett, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2018 June 30th | 2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 28.7 | -272 | -33.4 | -363 | -232 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 69.8 | 407 | 63 | 272 | 143 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -65.7 | 73.4 | 38.7 | -13 | 47.4 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | 119 | 176 | 116 | 60.9 | -7.13 |
| Capital Expenditures | -71.4 | -27.3 | -47.1 | -14.9 | -10.5 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 20.2 | 20.1 | 7.13 | 0.114 | 12.6 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -51.2 | -7.29 | -40 | -14.8 | 2.08 |
| Financing Cash Flow Items | 0 | -1.1 | -10.6 | -10.1 | 0 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -86.2 | -127 | -71.9 | -92.2 | -0.519 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -19.2 | 41.7 | 4.08 | -46 | -5.43 |